• Most Popular
  • Most Shared

CSL sees Talecris deal challenge resolved by August

Wed May 27, 2009 8:35pm EDT

Stocks

   

MELBOURNE, May 28 (Reuters) - Australian blood products group CSL Ltd (CSL.AX) said on Thursday it expects its challenge to a U.S. court injunction to block its $3.1 billion takeover of Talecris Biotherapeutics Holdings Corp to be resolved by August.

Stocks  |  Regulatory News  |  Mergers & Acquisitions  |  Funds News  |  ETFs News  |  Private Capital

CSL might have to pay a $75 million break fee to Talecris' private equity owners Cerberus Partners and Tribeca Investment Partners if the deal is not cleared by August 12.

"We anticipate that the preliminary injunction hearing can be held before that date," Managing Director Brian McNamee told reporters.

See [nN27278240] for more. (Reporting by Sonali Paul)

Stocks
Regulatory News
Mergers & Acquisitions
Funds News
ETFs News
Private Capital


More from Reuters

Photo

Honda expands airbag recall as more Toyotas probed

TOKYO/DETROIT (Reuters) - Honda Motor Co said it would recall another 440,000 cars around the world for faulty airbags as rival Toyota Motor Corp faced further probes over its largest-ever safety crisis. | Video

» More Top News
Chairman of the Federal Reserve Ben Bernanke testifies before the Senate Banking, Housing and Urban Affairs Committee on Capitol Hill in Washington July 22, 2009. REUTERS/Kevin Lamarque
John Kemp:

The Fed needs a new storyline

It's irrelevant whether the Fed sells its assets back to the market. What matters is whether and when it's prepared to raise rates.  Commentary 

Economy
A worker drives a Toyota Motor Corp's newly assembled Prius hybrid vehicle onto a trailer near the company's plant in Toyota, central Japan February 9, 2010.REUTERS/Yuriko Nakao
Reuters Breakingviews:

Toyota's troubles in overdrive

The cost of Toyota's recall nightmare is nothing compared to the price of fixing its battered reputation.  Commentary 

Autos